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Background. The NCEP metabolic syndrome (MetS) is a combination of dichotomized interrelated risk factors from
predominantly Caucasian populations. We propose a continuous MetS score based on principal component analysis (PCA) of
the same risk factors in a multiethnic cohort and compare prediction of incident CVD events with NCEP MetS definition.
Additionally, we replicated these analyses in the Health, Aging, and Body composition (Health ABC) study cohort. Methods and
Results. We performed PCA of the MetS elements (waist circumference, HDL, TG, fasting blood glucose, SBP, and DBP) in 2610
Caucasian Americans, 801 Chinese Americans, 1875 African Americans, and 1494 Hispanic Americans in the multiethnic study of
atherosclerosis (MESA) cohort.We selected the first principal component as a continuousMetS score (MetS-PC). Cox proportional
hazards models were used to examine the association between MetS-PC and 5.5 years of CVD events (n = 377) adjusting for age,
gender, race, smoking and LDL-C, overall and by ethnicity. To facilitate comparison of MetS-PC with the binary NCEP definition,
a MetS-PC cut point was chosen to yield the same 37% prevalence of MetS as the NCEP definition (37%) in the MESA cohort.
Hazard ratio (HR) for CVD events were estimated using the NCEP and Mets-PC-derived binary definitions. In Cox proportional
models, the HR (95% CI) for CVD events for 1-SD (standard deviation) of MetS-PC was 1.71 (1.54–1.90) (P < 0.0001) overall
after adjusting for potential confounders, and for each ethnicity, HRs were: Caucasian, 1.64 (1.39–1.94), Chinese, 1.39 (1.06–1.83),
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African, 1.67 (1.37–2.02), and Hispanic, 2.10 (1.66-2.65). Finally, when binary definitions were compared, HR for CVD events was
2.34 (1.91–2.87) for MetS-PC versus 1.79 (1.46–2.20) for NCEP MetS. In the Health ABC cohort, in a fully adjusted model, MetS-
PC per 1-SD (Health ABC) remained associated with CVD events (HR = 1.21, 95%CI 1.12–1.32) overall, and for each ethnicity,
Caucasian (HR = 1.24, 95%CI 1.12–1.39) and African Americans (HR = 1.16, 95%CI 1.01–1.32). Finally, when using a binary
definition of MetS-PC (cut point 0.505) designed to match the NCEP definition in terms of prevalence in the Health ABC cohort
(35%), the fully adjusted HR for CVD events was 1.39, 95%CI 1.17–1.64 compared with 1.46, 95%CI 1.23–1.72 using the NCEP
definition. Conclusion. MetS-PC is a continuous measure of metabolic syndrome and was a better predictor of CVD events overall
and in individual ethnicities. Additionally, a binary MetS-PC definition was better than the NCEP MetS definition in predicting
incident CVD events in the MESA cohort, but this superiority was not evident in the Health ABC cohort.
1. Introduction
Metabolic syndrome (MetS) is a constellation of interrelated
cardiovascular risk factors that increase the risk of developing
both atherosclerotic cardiovascular disease and Type 2 DM
[1]. It was recognized as a syndrome in 1988 [2] as it
reflects joint action of specific cardiovascular risk factors
whose underlying pathophysiology is thought to be related
to insulin resistance. Since then, various expert committees
have tried to refine the definition of MetS [1, 3–6], and
some have concluded that MetS in its current form is
imprecisely defined, leads to loss of critical information due
to dichotomization of continuous variables [7, 8], and has
uncertain value as a cardiovascular disease marker calling for
further research in this field. Thus, one school of thought
regarding the true nature of MetS asserts that MetS is
a representation of the true underlying pathophysiologic
pathways of dysmetabolic components [2]. Another view-
point is that MetS is a purely operational, arbitrary, and
convenient scoring methodology that summarizes risk [7, 8].
It is deficient in that it omits smoking and LDL-C and is
therefore not as efficient as the Framingham risk score and it
does not add new elements [7, 8]. The intention of this paper
is to highlight a methodology to improve upon the current
NCEP definition of MetS, in the sense of improving CVD
risk prediction using the same components as are included
in the MetS as currently defined [1].
The commonly used definition of MetS from National
Cholesterol Education Program/Adult Treatment Panel
(NCEP ATP III) [1, 9] is a score based on the presence or
absence of five dichotomized risk factors. When a subject
exceeds the cut point for three or more of these factors,
the syndrome is deemed to be present [1, 3]. However, it
is accepted that the risk for CVD from each element of
the MetS is continuous, and dichotomization above and
below certain thresholds does not lead to presence or absence
of CVD risk. Studies show that dichotomization of the
elements of MetS based on ad hoc cut points may lead
to misclassification of risk in individuals, despite minimal
changes in the actual elements or cardiovascular risk [10,
11]. Further, the summation of components into a unitary
diagnosis assumes that each dichotomized risk factor carries
the same risk, yet some factors included in NCEP MetS
definition are more strongly predictive of CVD than others
[8]. Additionally, the NCEP definition of MetS does not
account for racial differences and may not accurately predict
cardiovascular risk in non-Caucasian populations [12–16].
Principal component analysis is an analysis strategy de-
signed to summarize multidimensional correlated data [17,
18] and provide a continuous MetS score unlike factor
analysis [17, 18] which aims to determine the underlying
structure of the syndrome by identifying latent variables. The
unrotated first principal component is a linear combination
of the individual variables that captures the maximum
variance in the data among all possible linear combinations.
Since MetS is characterized by concomitant derangements in
multiple factors, the first principal component can be used to
indicate the extent to which any individual’s metabolic risk
factors are consistent with having the MetS. A few studies
have applied PCA to derive a continuous MetS score and
how this score relates to incident diabetes and cardiovascular
disease (CVD) [19–23]. This study is an extension and
validation of such findings in a multiethnic cohort.
2. Materials and Methods
2.1. Study Populations and Data Collection. TheMulti-Ethnic
Study of Atherosclerosis (MESA) design has been previously
described [24]. Briefly, MESA is a prospective cohort study
that began in July 2000 to investigate the prevalence,
correlates, and progression of subclinical CVD. It included
6814 men and women aged 44–84 years old recruited from
6 US communities (Baltimore, MD; Chicago, IL; Forsyth
County, NC; Los Angeles County, CA; northern Manhattan,
NY; St. Paul, MN). MESA cohort participants were 38%
Caucasian (n = 2622), 28% African American (n = 1893),
22% Hispanic (n = 1496), and 12% Chinese (n = 803).
Individuals with a history of physician-diagnosedmyocardial
infarction, angina, heart failure, stroke, or transient ischemic
attack, or who had undergone an invasive procedure for CVD
(coronary artery bypass graft, angioplasty, valve replacement,
pacemaker placement, or other vascular surgeries), were
excluded from the study at baseline (2000–2002). This study
was approved by the Institutional Review Boards of each
study site, and written informed consent was obtained from
all participants.
The Health, Aging and Body composition (Health ABC)
study is a longitudinal, prospective study investigating
the associations among body composition, weight-related
Health conditions, and incident functional limitations in
older adults [25]. The Health ABC study cohort consists
of 3,075 well-functioning black and white men and women
aged 70–79 at baseline (1997-1998). After excluding partici-
pants with missing data and prevalent cardiovascular disease
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at baseline, 2,159 participants were analyzed for 8.6 years for
incident CVD events.
2.2. Laboratory and Anthropometric Measurements. Partic-
ipants completed standardized medical history question-
naires. Fasting blood glucose and lipids were analyzed
at a central laboratory. Serum glucose was measured by
Vitros analyzer (Johnson & Johnson Clinical Diagnostics).
Impaired fasting glucose was defined as a fasting blood
glucose ≥100mg/dL and <126mg/dL. Diabetes was defined
by self-reported history of adult onset diabetes, fasting
glucose ≥126mg/dL, or use of insulin or oral glucose-
lowering medications. Plasma lipids (HDL cholesterol and
triglycerides) were measured using a standardized kit (Roche
Diagnostics). LDL cholesterol was calculated with the Friede-
wald equation [26]. Resting seated blood pressure was
measured three times using an automated oscillometric
sphygmomanometer (Dinamap PRO 100; Critikon, Tampa,
FL). The average of the last two measurements was used in
analysis. Elevated blood pressure was defined by use of blood
pressure medication or systolic blood pressure ≥130mmHg
or diastolic blood pressure≥85mmHg.Waist circumference
was measured at the umbilicus to the nearest 0.1 cm using a
steel measuring tape with standard 4-oz tension.
The National Cholesterol Education Program/Adult
Treatment Panel (NCEP ATP III) [1, 9] definition was used
to classify participants having MetS in the MESA cohort.
Three of five components are required for diagnosis. (1)
Waist circumference ≥ 102 cm: men, ≥88 cm: women, (2)
hypertension ≥ 130mmHg systolic or ≥85mmHg diastolic
or use of medications for hypertension, (3) fasting blood
glucose ≥ 100mg/dL or treatment for impaired fasting
glucose, (4) triglycerides ≥ 150mg/dL or specific treatment,
(5) HDL-C ≤ 40mg/dL in men and ≤50mg/dL in women.
2.3. Cardiovascular Events. A detailed description of events
and the process of adjudication can be found at the MESA
website (http://www.mesa-nhlbi.org/). Briefly, participants
were contacted every 9–12 months to inquire about hospital
admissions, cardiovascular diagnoses, and deaths. Hospi-
tal records were abstracted for possible CVD events and
were sent for review and classification by an independent
adjudication committee. For the purposes of this study, a
CVD event was defined as incident myocardial infarction,
resuscitated cardiac arrest, definite angina, probable angina if
followed by revascularization, stroke, stroke death, coronary
heart disease (CHD) death, other atherosclerotic death, and
other CVD deaths as defined by the MESA protocol.
2.4. Statistical Analysis. An ANOVA test was performed to
compare the mean values of the components of the MetS
across the four ethnic groups. A chi-square test was per-
formed to compare the proportion of individuals exceeding
the NCEP cut points for each component of the MetS across
the four ethnic groups. A principal component analysis using
studentized residuals of fasting log glucose, log triglycerides,
log HDL cholesterol, waist circumference, systolic blood
pressure, and diastolic blood pressure after adjusting for
age and gender was performed. A correlation matrix was
generated to measure the correlation between the individual
elements of the metabolic syndrome and the first principal
component. Principal component analysis was used for
the extraction of the initial factors. Principal component
analysis transforms the original variables into a new set of
uncorrelated factors (principal components) that account
for the maximum proportion of the variance in the data,
with each component being a linear combination of the
original observed variables. The first principal component
is the linear combination of variables that accounts for
the largest proportion of variance in the data, and the
second component is the combination that accounts for
the next largest proportion, and so on. Only components
with eigenvalues (the sum of the squared factor loadings,
representing the variance attributable to each principal
component) >1.0 are considered significant. A Kaplan-Meier
survival analysis was performed across quartiles of MetS-PC
to predict CVD events and a log rank test for trend overall
and in each ethnic group was performed. After excluding
subjects with missing data, a Cox regression proportional
hazards analysis was used to determine the association
between MetS-PC and 5.5-year incident CVD events in
the MESA cohort after adjusting for potential confounders
including age, gender, race, smoking, and LDL-C in nested
models.
In a separate sensitivity analysis, participants with dia-
betes were excluded, the first principal component was re-
calculated, and the association between MetS-PC and CVD
events was performed. Similar sensitivity analyses were per-
formed after excluding participants on anti-hypertensive
medications and anti-lipid medications. The patterns of as-
sociation observed between MetS-PC and CVD events in
these sensitivity analyses were qualitatively similar to the
results observed when using the first principal component
generated using the entire cohort (sensitivity analyses data
not shown), and thus the results for the entire cohort are
shown.
In a separate analysis, MetS-PC was recalculated using
the original six variables plus high-sensitivity C-reactive
protein (hsCRP). This new MetS-PC with seven compo-
nents was included in separate Cox proportional hazards
models with potential confounders to predict incident CVD
events.
To facilitate comparison of MetS-PC with the dichoto-
mous NCEP definition, a MetS-PC cut-point (0.475) was
chosen to yield the same 37% prevalence of metabolic
syndrome as when using the NCEP definition (37%) in
the MESA cohort. Separate Cox regression proportional
hazards models including NCEP MetS and a binary MetS-
PC to predict cardiovascular events were developed to
compare the relative strength of the association of the two
MetS definitions, and their model chi-square values were
compared.
Similar analyses were performed using the Health ABC
cohort to replicate and validate the findings from the MESA
cohort. All statistical analyses were performed using JMP
Version 8 (SAS Institute Inc., Cary, North Carolina).
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Table 1: Baseline Characteristics of the MESA cohort (2000–2002).
Race/ethnicity Caucasian Chinese African Hispanic P value
Participants 2610 801 1875 1494
Age 62.6 (10.2) 62.3 (10.3) 62.1 (10.1) 61.3 (10.3) 0.0009
Male 1259 (48%) 390 (48%) 843 (45%) 721 (48%) 0.06
Glucose ≥ 100mg/dL 835 (32%) 380 (47%) 853 (45%) 723 (48%) 0.0001
SBP ≥ 130mmHg 909 (35%) 303 (38%) 946 (50%) 596 (40%) 0.0001
DBP ≥ 85mmHg 195 (7%) 89 (11%) 285 (15%) 142 (9%) 0.0001
HDL ≤ 40, 50mg/dL (M, F) 947 (36%) 347 (43%) 694 (37%) 740 (49%) 0.0001
Triglyceride ≥ 150mg/dL 803 (31%) 276 (34%) 294 (16%) 638 (43%) 0.0001
Waist circ ≥ 102, 88 cm (M, F) 1409 (54%) 199 (25%) 1194 (63%) 921 (62%) 0.0001
Metabolic syndrome 862 (33%) 247 (31%) 721 (38%) 703 (47%) 0.0001
Fasting blood glucose (mg/dL) 98.4 (21.9) 106.1 (28.8) 107.2 (32.6) 110.8 (39.9) 0.0001
Systolic blood pressure (mmHg) 123.5 (20.4) 124.6 (21.6) 131.7 (21.6) 126.7 (21.9) 0.0001
Diastolic blood pressure (mmHg) 70.2 (9.9) 71.9 (10.3) 74.5 (10.2) 71.5 (10.1) 0.0001
High density lipoprotein (mg/dL) 52.2 (15.7) 49.5 (12.7) 52.4 (15.3) 47.6 (13.1) 0.0001
Triglyceride (mg/dL) 132.9 (90.2) 142.7 (84.8) 104.8 (68.6) 157.1 (101.1 0.0001
Waist circumference (cm) 97.9 (14.4) 87.1 (9.9) 101.2 (14.7) 100.6 (13.1) 0.0001
Hypertension 931 (36%) 311 (39%) 965 (51%) 606 (41%) 0.0001
Diabetes 140 (5%) 85 (11%) 300 (16%) 248 (17%) 0.0001
High cholesterol 1065 (41%) 286 (36%) 665 (35%) 522 (35%) 0.0003
Antihypertensive medications 691 (26%) 223 (28%) 911 (48%) 442 (30%) 0.0001
Diabetes medications 111 (4%) 77 (10%) 263 (14%) 214 (14%) 0.0001
Lipid medications 460 (18%) 118 (15%) 312 (16%) 211 (14%) 0.02
Never smokers 1157 (44%) 604 (75%) 850 (45%) 807 (54%)
Former smokers 1157 (44%) 153 (19%) 691 (36%) 486 (32%) 0.0001
Current smokers 301 (11%) 45 (6%) 338 (18%) 203 (14%)
P values obtained by one way analysis of variance. Data presented in total numbers (percentages) and continuous measures presented as mean value (standard
deviation). SBP, systolic blood pressure, mmHg; DBP, diastolic blood pressure, mmHg; HDL mg/dL: high density lipoprotein cholesterol; NCEP: metabolic
syndrome criteria (3 or more are required for diagnosis. (1) waist circumference ≥ 102 cm: men, ≥88 cm: women, (2) hypertension ≥ 130mmHg systolic or
≥85mmHg diastolic, (3) fasting blood glucose ≥ 100mg/dL or treatment for impaired fasting glucose or diabetes, (4) triglycerides ≥ 150mg/dL or specific
treatment, and (5) HDL-C < 40mg/dL in men and <50mg/dL in women).
3. Results
3.1. Participant Characteristics. Among 6,814 MESA partic-
ipants, we excluded 34 due to missing MetS component
data. The baseline characteristics of the 6,780 participants
are shown in Table 1. There are significant differences in
the prevalence of the elements of the MetS between the
ethnic groups. The mean age of the participants in each
ethnicity is 62 years, and more than 50% are females in each
ethnicity. The first principal component explains 33% of
the total variance among these measures, and the measured
correlations are: waist circumference (0.56), systolic blood
pressure (0.61), diastolic blood pressure (0.56), glucose
(0.44), high-density lipoprotein (−0.51), and triglycerides
(0.51). (Table 2) Consistent with the notion of a syndrome
with highly correlated measures, all MetS-PC correlation
coefficients were above 0.40, and the eigenvalue for the first
principal component is 2.0.
3.2. Cardiovascular Events. During 5.5 years of followup, 377
CVD events were identified (160 Caucasian, 30 Chinese, 105
Table 2: The correlation between the original elements ofmetabolic
syndrome and MetS-PC (first principal component).
MetS components MetS-PC
Waist circumference 0.56 (0.54,0.58)
Systolic blood pressure 0.61 (0.60,0.63)
Diastolic blood pressure 0.56 (0.54,0.57)
Glucose 0.44 (0.42,0.45)
High-density lipoprotein −0.51 (−0.53,−0.49)
Triglyceride 0.51 (0.49,0.53)
African, and 82 Hispanic). A Kaplan-Meier survival curve
shows decreased survival free of CVD events across quartiles
of MetS-PC with a log test for trend which is statistically
significant (P < 0.0001) (Figure 1). After stratification by
ethnicity, similar results were obtained for each ethnicity
separately (Chinese: P = 0.02, all other ethnicities: P <
0.001).
When treated as a continuous measure, each unit differ-
ence of standard deviation (SD) ofMetS-PC was significantly
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Figure 1: Kaplan-Meier survival curves for CVD events across
quartiles of MetS-PC in MESA cohort after 5.5 years of followup.
MetS-PC: quartile 1 < −0.96, quartile 2 > −0.96 to < −0.02,
quartile 3 > −0.02 to < 0.93, and quartile 4 > 0.93.
associated with CVD events with a univariate hazard ratio
of 1.56, 95%CI 1.42–1.72 (Table 3). In a full model adjusted
for age, gender, race, smoking, and LDL-C, MetS-PC per
unit difference of SD remained significantly associated with
CVD events (HR = 1.71, 95%CI 1.54–1.90). Additionally in
similar analysis stratified by ethnicity, hazard ratio remained
significant in each ethnicity separately in both unadjusted
and adjusted models (Table 3).
The prediction of CVD events using MetS-PC with seven
components including hsCRP was not significantly different
than the more parsimonious MetS-PC definition with the
original six variables (data not shown).
Finally, when using a binary definition of MetS-PC (cut
point 0.475) designed to match the NCEP definition in terms
of prevalence in the MESA cohort, the fully adjusted HR
for CVD events was 2.34, 95%CI 1.91–2.87 compared with
1.79, 95%CI 1.46–2.20 when using the NCEP definition
(Table 4). A similar pattern of improved prediction of CVD
events using the binary MetS-PC definition compared with
the NCEP definition was also observed in each ethnicity
separately. The sensitivity and specificity of the binary MetS-
PC definition for prediction of CVD was 54% and 65%,
respectively, compared with 51.7% and 63.5% using the
NCEP definition. The formula for calculating MetS-PC is
((−11.8769) + (1.5432298∗ Log Glucose) + (0.7872732 ∗
Log Triglyceride) − (1.588791 ∗ Log HDL) + (0.0277125 ∗
waist circumference) + (0.0232299 ∗ SBP) + (0.0420722 ∗
DBP) − (0.016408 ∗ Age) − (0.73821 ∗ Gender) Male = 1,
Female = 0).
Finally, we performed an independent validation of the
analysis using the Health ABC cohort. In a full model
adjusted for age, gender, race, smoking, and LDL-C, MetS-
PC per 1-SD (HABC) remained significantly associated with
CVD events (HR = 1.21, 95%CI 1.12–1.32) overall, and by
each ethnicity, Caucasian (HR = 1.24, 95%CI 1.12–1.39)
Table 3: Cox proportional Hazard models illustrating the asso-
ciation of MetS-PC per change in one SD with CVD events in
the MESA cohort after 5.5 years of follow up overall and by
race/ethnicity.
HR 95% CI P value
Model 1
Overall 1.56 1.42, 1.72 0.0001
Caucasian 1.59 1.37, 1.84 0.0001
Chinese 1.42 0.99, 2.01 0.06
African 1.46 1.21, 1.75 0.0001
Hispanic 1.84 1.48, 2.30 0.0001
Model 2
Overall 1.65 1.49, 1.82 0.0001
Caucasian 1.61 1.38, 1.87 0.0001
Chinese 1.49 1.03, 2.15 0.04
African 1.61 1.34, 1.92 0.0001
Hispanic 1.92 1.54, 2.40 0.0001
Model 3
Overall 1.71 1.54, 1.90 0.0001
Caucasian 1.64 1.39, 1.94 0.0001
Chinese 1.59 1.08, 2.35 0.02
African 1.67 1.37, 2.02 0.0001
Hispanic 2.10 1.66, 2.65 0.0001
Standardized MetS-PC; mean (SD), −0.00056 (1); model 1, univariate
analysis; model 2, adjusted for age and gender; model 3, model 2, plus
cigarette smoking and low-density lipoprotein; the overall hazards were
further adjusted for race/ethnicity in models 2 and 3.
and African Americans (HR = 1.16, 95%CI 1.01–1.32).
Finally, when using a binary definition ofMetS-PC (cut point
0.505) designed to match the NCEP definition in terms of
prevalence in the Health ABC cohort, the fully adjusted HR
for CVD events was 1.39, 95%CI 1.17–1.64 compared with
1.46, 95%CI 1.23–1.72 when using the NCEP definition.
4. Discussion
In this ethnically diverse population of 6,780 individuals
aged 45–84, the first principal component derived from
elements of the MetS explains 33% of the variance of the
metabolic measures. This continuous metabolic syndrome
score (MetS-PC) is a significant predictor of 5.5-year incident
clinical cardiovascular events in the total population, and in
each of the four major race/ethnicity subgroups separately.
Additionally, a binary definition of the MetS based on
this continuous measure was a better predictor of clinical
cardiovascular events compared to the NCEP definition.
It should be acknowledged that MetS is not an absolute
risk indicator, because it does not contain many of the factors
that determine absolute risk, for example, age, sex, cigarette
smoking, and low-density lipoprotein cholesterol levels [6].
Risk predictors such as the Framingham risk score are much
superior if risk prediction is the goal; however, the primary
goal of this analysis was not risk prediction per se, but rather
improving upon the current NCEP definition of MetS, using
6 Cardiology Research and Practice
Table 4: Cox proportional hazard models illustrating the association of NCEP and binary MetS-PC MetS definitions with CVD events in
the MESA cohort.
All cardiovascular events (n = 377)
All CVD NCEP MetS MetS-PC MetS
HR 95% CI P value χ2 value HR 95% CI P value χ2 value
Model 1
Overall 1.87 1.53, 2.28 0.0001 37 2.14 1.75, 2.62 0.0001 55
Caucasian 1.99 1.47, 2.71 0.0001 19 1.97 1.45, 2.68 0.0001 19
Chinese 1.49 0.72, 3.10 0.28 1 1.61 0.78, 3.35 0.19 2
African 1.74 1.18, 2.54 0.005 8 2.21 1.50, 3.27 0.0001 16
Hispanic 1.99 1.28, 3.11 0.002 9 2.88 1.81, 4.60 0.0001 20
Model 2
Overall 1.78 1.45, 2.18 0.0001 31 2.32 1.89, 2.84 0.0001 66
Caucasian 1.85 1.36, 2.52 0.0001 15 1.98 1.45, 2.69 0.0001 19
Chinese 1.42 0.68, 2.99 0.35 1 1.71 0.82, 3.57 0.15 2
African 1.73 1.18, 2.55 0.005 8 2.66 1.79, 3.94 0.0001 24
Hispanic 1.86 1.19, 2.91 0.007 7 3.10 1.94, 4.96 0.0001 22
Model 3
Overall 1.79 1.46, 2.20 0.0001 31 2.34 1.91, 2.87 0.0001 67
Caucasian 1.84 1.35, 2.51 0.0001 15 1.95 1.43, 2.67 0.0001 18
Chinese 1.50 0.71, 3.17 0.28 1 1.80 0.86, 3.77 0.12 2
African 1.75 1.19, 2.57 0.004 8 2.68 1.81, 3.98 0.0001 24
Hispanic 1.92 1.22, 3.03 0.005 8 3.38 2.09, 5.44 0.0001 25
Model 1, univariate analysis; model 2, adjusted for age and gender; model 3, model 2, plus cigarette smoking and low-density lipoprotein; the overall hazards
were further adjusted for race/ethnicity in models 2 and 3; CVD, cardiovascular disease; NCEP MetS (binary variables); MetS-PC (binary variables, with the
cut point being 0.475); HR hazards ratio.
the same components that make the MetS and comparing
the two definitions using incident CVD events as a criteria
measure.
The current binary definitions of the metabolic syn-
drome, including the NCEP definition, were developed by
expert committees as a clinically useful means of identifying
high-risk individuals [1, 3–6]. However, dichotomization of
the continuous variables leads to loss of information [7, 8].
A minor improvement in one component could result in an
individual no longer being classified as having MetS, despite
no meaningful change of actual cardiovascular risk [11].
Additionally, the NCEP MetS may not predict risk of CVD
events in all ethnicities equally as the data for constructing
the NCEP definition were derived from predominantly Cau-
casian populations [12–16]. The evaluation of the MetS as
a continuous score derived from a multiethnic population is
potentially a more informative and generalizable approach to
defining the syndrome and determining its clinical correlates.
Additionally, a continuous measure may also improve the
ability to identify lifestyle, environmental, molecular, and
genetic etiologic factors that are specific for the MetS, and in
future, these etiological factors could be incorporated in the
definition of the continuous measure providing a stronger
CVD predictive value [7].
Principal component analysis is a mathematical tech-
nique that transforms a number of correlated variables into
a reduced number of uncorrelated variables called principal
components, of which the first principal component captures
the maximal variance [17, 18, 27]. Since the MetS is a
metabolic condition characterized by the co-occurrence of
multiple metabolic abnormalities, it follows that the first
principal component of the measures for these traits would
be an efficient way to quantify the presence of the syndrome.
In our data,MetS-PC correlated well with all the components
of the MetS (correlation coefficients 0.44–0.61, Table 2),
consistent with a definition of a syndrome.
The metabolic syndrome is a known risk factor for car-
diovascular disease, and MetS-PC predicts clinical cardio-
vascular events extremely well in this multiethnic cohort.
MetS-PC was significantly associated with a more than
twofold, fully adjusted increased risk of incident CVD in
this cohort. We choose to show the analysis in the entire
cohort including also diabetics as the analysis after excluding
diabetics was qualitatively similar to the results obtained with
the entire cohort. In analyses stratified by ethnicity, MetS-
PC is a significant predictor of CVD across the four ethnic
groups with similar point estimates for the hazard ratios.
Additionally, there are suggestions that perhaps for better
risk prediction; the definition of metabolic syndrome should
be broadened to incorporate other elements such as high-
sensitivity C-reactive protein (hsCRP) in the MetS definition
[7, 28]. We performed an analysis wherein we added hsCRP
in the MetS-PC, but the addition did not lead to any
substantial improvement in risk prediction of incident CVD
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events. Our findings parallel similar results where addition of
hsCRP to MetS did not lead to improvement in prediction of
incident CVD events [29] or atherogenesis [30].
Further, we compared the MetS-PC definition of MetS
with the NCEP definition in predicting CVD events in the
MESA cohort. To facilitate comparison of MetS-PC with
the dichotomous NCEP definition, a MetS-PC cut point
(0.475) was chosen to yield the same 37% prevalence of
MetS as when using the NCEP definition (37%) in the
MESA cohort. The strength of association with incident car-
diovascular events was compared using the NCEP and the
derived binary MetS-PC definitions, in a fully adjusted
model. The binary MetS-PC has a stronger association with
incident cardiovascular events compared to the NCEP MetS
as the point estimate for hazard using the binary MetS-
PC definition is not included in the confidence interval of
the NCEP hazard ratio. Additionally, the chi-square values
were much higher when using the binaryMetS-PC definition
compared to the NCEP MetS definition. However, when an
independent validation of a similar strategy was applied in
the Health ABC cohort, the association of MetS-PC with
CVD events remained, but the superiority of the MetS-
PC definition versus NCEP MetS definition was no longer
evident. This could be the result of the inherent differences
between the two cohorts such as differences in age. The mean
age of the MESA cohort is 62 years versus 74 for the Health
ABC cohort. Additionally, the overall mean age and gender-
adjusted systolic and diastolic blood pressures are much
lower in the MESA cohort as compared to the Health ABC
cohort. This is reflected in the loading for the first principal
component. Both the systolic and diastolic blood pressures
are well represented in the first principal component in the
MESA cohort (loading factors: systolic BP = 0.61, diastolic
BP = 0.56). In contrast, the systolic and diastolic BP were
less heavily represented in the PC analysis for the Health
ABC cohort (loading factors: systolic BP = 0.13, diastolic
BP = 0.05), perhaps secondary to the greater prevalence of
essential hypertension uncorrelated with the other metabolic
derangements of the Met syndrome. In a previous Health
ABC study evaluating CVD risk in older adults with MetS
without past history of coronary heart disease and heart
failure, the proportion of MI (6.1% versus 4.8%, P = 0.18)
and HF hospital stay (5.6% versus 4.3%, P = 0.17), although
higher among those with MetS compared to those without
MetS, did not reach statistical significance [31]. This finding
perhaps explains the lower hazards for CVD events in the
Health ABC cohort compared to the MESA cohort findings.
A few studies have applied PCA to identify factors and
their relationship to incident diabetes and cardiovascular
disease (CVD) using the elements of the MetS, measures
of obesity, and insulin resistance [19–22]. Hillier et al.,
[22] found increased odds of cardiovascular events in 5,024
middle-aged French cohort; men, 1.7 (1.4, 2.1), and women
1.7 (1.0, 2.7), which is similar to our findings of 1.71 (1.54,
1.90). Lempiainen et al., [19] applied factor analysis to 1069
subjects 65 to 74 years old from Finland followed for a period
of 7 years and found similar hazards of coronary events.
Similarly, Pyo¨ra¨la¨ et al., [23] applied factor analysis to 970
healthy men aged 34 to 64 years in the Helsinki Policemen
Study and found that the insulin resistance factor increased
the hazard for coronary heart disease to 1.28 (95% CI 1.10–
1.50) during 22 years of followup. The current study builds
on these earlier efforts by applying similar methods to a
larger andmuchmore ethnically diverse cohort. The strength
of the association between the continuous MetS-PC score
and CVD events, its utility for predicting CVD events in
multiple ethnicities, and its improved performance relative
to the NCEP definition provide compelling evidence that
this approach may be a superior strategy for defining the
metabolic syndrome.
The strength of this study is the inclusion of four different
ethnicities from six different recruitment sites in the United
States, and stringent quality control procedures, as well as
an average 5.5-year followup for identification of incident
cardiovascular events. Additionally, we performed a replica-
tion of the strategy using an independent cohort and found
results to be qualitatively similar. Among its limitations,
the exclusion of individuals with known cardiovascular
disease calls for caution in generalizing results to the total
population. It should also be emphasized that acculturation
to diet and environment plays a role in the development
of the cardiovascular disease, and therefore, our findings
may not apply to the same ethnicities in other parts of the
world. Additionally, the sample size for Chinese Americans
was small, and the event rate was low, making the estimates
of risk less certain in the Chinese American participants
compared with other groups. Further, this continuous score
will need to be validated in larger cohorts before finding
general applicability.
5. Conclusion
In this multi-ethnic population, the first principal compo-
nent derived from the elements of the metabolic syndrome
represents a continuous metabolic syndrome score which
significantly predicts clinical cardiovascular events overall
and across all ethnicities. Additionally, when a binary score
derived from the first principal component was compared
to the NCEP definition of MetS in the MESA cohort, the
binary MetS-PC score was a better predictor of incident
cardiovascular events than the NCEP definition of the
metabolic syndrome. However, in the Health ABC cohort,
although results were qualitatively similar, the MetS-PC
definition was not found to be superior to the NCEP
definition of MetS. This strategy will need to be replicated
in other large multi-ethnic cohorts and, if also predictive of
incident diabetes, it could be considered as an alternative
to the conventional metabolic syndrome definition. More
research will be required to clarify if and how such a score
could be incorporated into clinical practice.
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